HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malabendu Jana Selected Research

Gemfibrozil (Lopid)

10/2021Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARα-Dependent Astrocytic GDNF Pathway.
10/2012Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor-β.
8/2012Gemfibrozil, a lipid lowering drug, inhibits the activation of primary human microglia via peroxisome proliferator-activated receptor β.
10/2007Gemfibrozil ameliorates relapsing-remitting experimental autoimmune encephalomyelitis independent of peroxisome proliferator-activated receptor-alpha.
11/2002Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Malabendu Jana Research Topics

Disease

13Multiple Sclerosis
11/2018 - 10/2002
10Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2020 - 04/2003
5Demyelinating Diseases (Demyelinating Disease)
11/2018 - 10/2007
4Inflammation (Inflammations)
10/2021 - 12/2017
4Parkinson Disease (Parkinson's Disease)
10/2021 - 01/2019
4Neurodegenerative Diseases (Neurodegenerative Disease)
04/2019 - 12/2007
4Alzheimer Disease (Alzheimer's Disease)
01/2019 - 11/2008
4Neuroinflammatory Diseases
11/2007 - 11/2002
3COVID-19
12/2021 - 10/2020
2Vesicular Stomatitis
12/2021 - 11/2021
2Fever (Fevers)
12/2021 - 01/2021
2Amyloid Plaque
01/2019 - 01/2018
2Autoimmune Diseases (Autoimmune Disease)
06/2003 - 10/2002
1Pneumonia (Pneumonitis)
12/2021
1Dementia (Dementias)
10/2021
1Multiple System Atrophy
10/2021
1Coronary Disease (Coronary Heart Disease)
10/2021
1Acquired Immunodeficiency Syndrome (AIDS)
01/2021
1Murine Acquired Immunodeficiency Syndrome (MAIDS)
01/2021
1Chronic Disease (Chronic Diseases)
11/2018
1Experimental Arthritis
10/2018
1Wounds and Injuries (Trauma)
12/2017
1Infections
12/2017
1Burns
12/2017
1Starvation
12/2016
1Hyperlipidemias (Hyperlipidemia)
10/2007
1Relapsing-Remitting Multiple Sclerosis
10/2007
1Inborn Urea Cycle Disorders
04/2003

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
10/2021 - 11/2002
5Therapeutic UsesIBA
10/2021 - 11/2002
5Gemfibrozil (Lopid)FDA LinkGeneric
10/2021 - 11/2002
5Peptides (Polypeptides)IBA
10/2021 - 07/2004
3Angiotensin-Converting Enzyme 2IBA
12/2021 - 01/2021
3cinnamic acidIBA
04/2019 - 01/2018
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019 - 01/2018
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2016 - 08/2012
2LipidsIBA
10/2021 - 10/2007
2Interleukin-12 (IL 12)IBA
01/2020 - 04/2014
2Interleukin-23 (Interleukin 23)IBA
01/2020 - 04/2014
2Amyloid beta-PeptidesIBA
01/2019 - 11/2008
2Myelin Basic ProteinIBA
11/2018 - 09/2005
2NF-kappa B (NF-kB)IBA
11/2007 - 11/2002
2AntigensIBA
06/2003 - 10/2002
1EugenolIBA
12/2021
1HDL CholesterolIBA
10/2021
1SynucleinsIBA
10/2021
1LDL CholesterolIBA
10/2021
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
10/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1CurcuminIBA
10/2020
1ZincIBA
10/2020
1Protein AggregatesIBA
01/2019
1Dopamine (Intropin)FDA LinkGeneric
01/2019
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
01/2019
1Myelin ProteinsIBA
11/2018
1Phosphatidylinositols (Phosphatidylinositol)IBA
02/2018
1RNS60IBA
02/2018
1Amyloid (Amyloid Fibrils)IBA
01/2018
1HydrogelsIBA
12/2017
1Ointments (Pastes)IBA
12/2017
1TriazolesIBA
12/2017
1LigninIBA
12/2017
1Fatty Acids (Saturated Fatty Acids)IBA
12/2016
1Ciliary Neurotrophic Factor (CNTF)IBA
11/2015
1LigandsIBA
08/2015
1Simvastatin (Zocor)FDA LinkGeneric
08/2015
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2015
1Interleukin-7 (Interleukin 7)IBA
04/2014
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2013
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2012
1Lymphotoxin-alpha (Lymphotoxin)IBA
07/2009
1Interleukin-16 (Interleukin 16)IBA
02/2009
1Chemotactic FactorsIBA
02/2009
1Phosphotransferases (Kinase)IBA
11/2007
1AcetyltransferasesIBA
11/2007
1PPAR alphaIBA
10/2007
1CytokinesIBA
09/2005
1Nitric Oxide Synthase (NO Synthase)IBA
09/2005
1I-kappa B KinaseIBA
07/2004
14-phenylbutyric acid (Buphenyl)FDA Link
04/2003
1phenylacetic acid (phenylacetate)FDA Link
04/2003
1Drinking WaterIBA
04/2003
1CCAAT-Enhancer-Binding Protein-betaIBA
11/2002
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
11/2002

Therapy/Procedure

3Therapeutics
01/2021 - 12/2007
2Oral Administration
01/2018 - 11/2015
1Intranasal Administration
10/2021